RESUMEN
The ability to cryopreserve mosquitoes would revolutionize work on these vectors of major human infectious diseases by conserving stocks, new isolates, lab-bred strains, and transgenic lines that currently require continuous life cycle maintenance. Efforts over several decades to develop a method for cryopreservation have, until now, been fruitless: we describe here a method for the cryopreservation of Anopheles stephensi embryos yielding hatch rates of ~ 25%, stable for > 5 years. Hatched larvae developed into fertile, fecund adults and blood-fed females, produced fully viable second generation eggs, that could be infected with Plasmodium falciparum at high intensities. The key components of the cryopreservation method are: embryos at 15-30 min post oviposition, two incubation steps in 100% deuterated methanol at - 7 °C and - 14.5 °C, and rapid cooling. Eggs are recovered by rapid warming with concomitant dilution of cryoprotectant. Eggs of genetically modified A. stephensi and of A. gambiae were also successfully cryopreserved. This enabling methodology will allow long-term conservation of mosquitoes as well as acceleration of genetic studies and facilitation of mass storage of anopheline mosquitoes for release programs.
Asunto(s)
Anopheles/embriología , Criopreservación/métodos , Embrión no Mamífero/embriología , Animales , Anopheles/parasitología , Crioprotectores , Larva/crecimiento & desarrollo , Oviposición , Plasmodium falciparum/parasitologíaRESUMEN
Transplanted patients are particularly exposed to a major risk of infectious diseases due to prolonged immunosuppressive treatment. Over the last decade, the growing migration flows and the transplant tourism have led to increasing infections caused by geographically restricted organisms. Malaria is an unusual event in organ transplant recipients than can be acquired primarily or reactivation following immunosuppression, by transfusion of blood products or through the transplanted organ. We report a rare case of Plasmodium falciparum infection in a liver transplanted two years-old African boy who presented to one Italian Asylum Seeker Center on May 2019. We outlined hereby diagnostic challenges, possible aetiologies of post-transplantation malaria and finally we summarized potential drug interactions between immunosuppressive agents and antimalarials. This report aims to increase the attention to newly arrived migrants, carefully evaluating patients coming from tropical areas and taking into consideration also rare tropical infections not endemic in final destination countries.
Asunto(s)
Malaria Falciparum/diagnóstico , Antimaláricos/uso terapéutico , Arteméter/uso terapéutico , Artesunato/uso terapéutico , Preescolar , Humanos , Trasplante de Hígado/efectos adversos , Lumefantrina/uso terapéutico , Malaria Falciparum/tratamiento farmacológico , Masculino , Plasmodium falciparum/parasitología , Migrantes , Receptores de Trasplantes , Resultado del TratamientoRESUMEN
INTRODUCTION: A safe and effective vaccine will likely be necessary for the control or eradication of malaria which kills 400,000 annually. Our most advanced vaccine candidate to date is RTS,S which is based on the Plasmodium falciparum circumsporozoite protein (PfCSP) of the malaria parasite. However, protection by RTS,S is incomplete and short-lived. AREAS COVERED: Here we summarize results from recent clinical trials of RTS,S and critically evaluate recent studies that aim to understand the correlates of protective immunity and why vaccine-induced protection is short-lived. In particular, recent systems serology studies have highlighted a key role for the necessity of inducing functional antibodies. In-depth analyses of immune responses to CSP in both mouse models and vaccinated humans have also highlighted difficulties in generating the maintaining high-quality antibody responses. Finally, in recent years biophysical and structural studies of antibody binding to PfCSP have led to a better understanding of how highly potent antibodies can block infection, which can inform vaccine design. EXPERT OPINION: We highlight how both structure-guided vaccine design and a better understanding of the immune response to PfCSP can inform a second generation of PfCSP-based vaccines stimulating a broader range of protective targets within PfCSP.
Asunto(s)
Vacunas contra la Malaria/administración & dosificación , Malaria Falciparum/prevención & control , Plasmodium falciparum/inmunología , Animales , Anticuerpos Antiprotozoarios/inmunología , Humanos , Vacunas contra la Malaria/inmunología , Malaria Falciparum/inmunología , Ratones , Plasmodium falciparum/parasitología , Proteínas Protozoarias/inmunología , Factores de TiempoRESUMEN
Introduction: The development of effective vaccines remains a major health priority to combat the global burden of malaria, a life-threatening disease caused by Plasmodium parasites. Transmission-blocking vaccines (TBVs) elicit antibodies that neutralize the sexual stages of the parasite in blood meals ingested by the Anopheles mosquito, interrupting parasite development in the vector host and preventing disease spread to other individuals.Areas covered: The P. falciparum gametocyte surface antigens Pfs230, Pfs48/45, and Pfs47, the parasite ookinete surface protein Pfs25, and the male gametocyte specific protein PfHAP2 are leading TBV candidates, some of which are in clinical development. The recent expansion of methodology to study monoclonal antibodies isolated directly from humans and animal models, coupled with effective measures for parasite neutralization, has provided unprecedented insight into TBV efficacy and development.Expert opinion: Available structural and functional data on antigen-monoclonal antibody (Ag-mAb) complexes, as well as epitope classification studies, have identified neutralizing epitopes that may aid vaccine development and improve protection. Here, we review the clinical prospects of TBV candidates, progress in the development of novel vaccine strategies for TBVs, and the impact of structural vaccinology in TBV design.
Asunto(s)
Vacunas contra la Malaria/administración & dosificación , Malaria Falciparum/prevención & control , Plasmodium falciparum/inmunología , Animales , Anopheles/parasitología , Anticuerpos Monoclonales/inmunología , Anticuerpos Antiprotozoarios/inmunología , Antígenos de Protozoos/inmunología , Humanos , Vacunas contra la Malaria/inmunología , Malaria Falciparum/inmunología , Malaria Falciparum/transmisión , Mosquitos Vectores/inmunología , Mosquitos Vectores/parasitología , Plasmodium falciparum/parasitología , VacunologíaRESUMEN
Although current malaria therapies inhibit pathways encoded in the parasite's genome, we have looked for anti-malaria drugs that can target an erythrocyte component because development of drug resistance might be suppressed if the parasite cannot mutate the drug's target. In search for such erythrocyte targets, we noted that human erythrocytes express tyrosine kinases, whereas the Plasmodium falciparum genome encodes no obvious tyrosine kinases. We therefore screened a library of tyrosine kinase inhibitors from Eli Lilly and Co. in a search for inhibitors with possible antimalarial activity. We report that although most tyrosine kinase inhibitors exerted no effect on parasite survival, a subset of tyrosine kinase inhibitors displayed potent anti-malarial activity. Moreover, all inhibitors found to block tyrosine phosphorylation of band 3 specifically suppressed P. falciparum survival at the parasite egress stage of its intra-erythrocyte life cycle. Conversely, tyrosine kinase inhibitors that failed to block band 3 tyrosine phosphorylation but still terminated the parasitemia were observed to halt parasite proliferation at other stages of the parasite's life cycle. Taken together these results suggest that certain erythrocyte tyrosine kinases may be important to P. falciparum maturation and that inhibitors that block these kinases may contribute to novel therapies for P. falciparum malaria.
Asunto(s)
Malaria Falciparum/tratamiento farmacológico , Inhibidores de Proteínas Quinasas/farmacología , Quinasa Syk/antagonistas & inhibidores , Animales , Antimaláricos/uso terapéutico , Eritrocitos/efectos de los fármacos , Eritrocitos/metabolismo , Femenino , Voluntarios Sanos , Humanos , Malaria/tratamiento farmacológico , Malaria Falciparum/parasitología , Masculino , Parasitemia/tratamiento farmacológico , Parásitos/metabolismo , Biblioteca de Péptidos , Fosforilación , Plasmodium falciparum/efectos de los fármacos , Plasmodium falciparum/metabolismo , Plasmodium falciparum/parasitología , Proteínas Tirosina Quinasas/antagonistas & inhibidores , Proteínas Tirosina Quinasas/metabolismo , Quinasa Syk/metabolismoRESUMEN
BACKGROUND: Low-density (LD) Plasmodium infections are missed by standard malaria rapid diagnostic tests (standard mRDT) when the blood antigen concentration is below the detection threshold. The clinical impact of these LD infections is unknown. This study investigates the clinical presentation and outcome of untreated febrile children with LD infections attending primary care facilities in a moderately endemic area of Tanzania. METHODS/FINDINGS: This cohort study includes 2,801 febrile pediatric outpatients (median age 13.5 months [range 2-59], female:male ratio 0.8:1.0) recruited in Dar es Salaam, Tanzania between 01 December 2014 and 28 February 2016. Treatment decisions were guided by a clinical decision support algorithm run on a mobile app, which also collected clinical data. Only standard mRDT+ cases received antimalarials. Outcomes (clinical failure, secondary hospitalization, and death) were collected in follow-up visits or interviews on days 3, 7, and 28. After patient recruitment had ended, frozen blood from all 2,801 patients was tested for Plasmodium falciparum (Pf) by ultrasensitive-quantitative polymerase chain reaction (qPCR), standard mRDT, and "ultrasensitive" mRDT. As the latter did not improve sensitivity beyond standard mRDT, it is hereafter excluded. Clinical features and outcomes in LD patients (standard mRDT-/ultrasensitive-qPCR+, not given antimalarials) were compared with those with no detectable (ND) parasitemia (standard mRDT-/ultrasensitive-qPCR-) or high-density (HD) infections (standard mRDT+/ultrasensitive-qPCR+, antimalarial-treated). Pf positivity rate was 7.1% (n = 199/2,801) and 9.8% (n = 274/2,801) by standard mRDT and ultrasensitive qPCR, respectively. Thus, 28.0% (n = 76/274) of ultrasensitive qPCR+ cases were not detected by standard mRDT and labeled "LD". LD patients were, on average, 10.6 months younger than those with HD infections (95% CI 7.0-14.3 months, p < 0.001). Compared with ND, LD patients more frequently had the diagnosis of undifferentiated fever of presumed viral origin (risk ratio [RR] = 2.0, 95% CI 1.3-3.1, p = 0.003) and were more often suffering from severe malnutrition (RR = 3.2, 95% CI 1.1-7.5, p = 0.03). Despite not receiving antimalarials, outcomes for the LD group did not differ from ND regarding clinical failures (2.6% [n = 2/76] versus 4.0% [n = 101/2,527], RR = 0.7, 95% CI 0.2-3.5, p = 0.7) or secondary hospitalizations (2.6% [n = 2/76] versus 2.8% [n = 72/2,527], RR = 0.7,95% CI 0.2-3.2, p = 0.9), and no deaths were reported in any Pf-positive groups. HD patients experienced more secondary hospitalizations (10.1% [n = 20/198], RR = 0.3, 95% CI 0.1-1.0, p = 0.005) than LD patients. All the patients in this cohort were febrile children; thus, the association between parasitemia and fever cannot be investigated, nor can the conclusions be extrapolated to neonates and adults. CONCLUSIONS: During a 28-day follow-up period, we did not find evidence of a difference in negative outcomes between febrile children with untreated LD Pf parasitemia and those without Pf parasitemia. These findings suggest LD parasitemia may either be a self-resolving fever or an incidental finding in children with other infections, including those of viral origin. These findings do not support a clinical benefit nor additional risk (e.g. because of missed bacterial infections) to using ultrasensitive malaria diagnostics at a primary care level.
Asunto(s)
Parasitemia/diagnóstico , Convulsiones Febriles/etiología , Convulsiones Febriles/parasitología , Antimaláricos/uso terapéutico , Preescolar , Estudios de Cohortes , Femenino , Fiebre/diagnóstico , Humanos , Lactante , Malaria/epidemiología , Malaria Falciparum/tratamiento farmacológico , Masculino , Parasitemia/epidemiología , Plasmodium falciparum/parasitología , Plasmodium falciparum/patogenicidad , Tanzanía/epidemiologíaRESUMEN
Kerteszia cruzii is a sylvatic mosquito and the primary vector of Plasmodium spp., which can cause malaria in humans in areas outside the Amazon River basin in Brazil. Anthropic changes in the natural environments are the major drivers of massive deforestation and local climate change, with serious impacts on the dynamics of mosquito communities and on the risk of acquiring malaria. Considering the lack of information on the dynamics of malaria transmission in areas across the Atlantic Forest biome, where Ke. cruzii is the dominant vector, and the impact of climate drivers of malaria, the present study aimed to: (i) investigate the occurrence and survival rate of Ke. cruzii based on the distinct vegetation profiles found in areas across the coastal region of the Brazilian Atlantic Forest biome; (ii) estimate the extrinsic incubation period (EIP) and survival rates of P. vivax and P. falciparum parasites in Ke. cruzii under current and future scenarios. The potential distribution of Plasmodium spp. was estimated using simulation analyses under distinct scenarios of average temperature increases from 1 °C to 3.7 °C. Our results showed that two conditions are necessary to explain the occurrence and survival of Ke. cruzii: warm temperature and presence of the Atlantic Forest biome. Moreover, both Plasmodium species showed a tendency to decrease their EIP and increase their estimated survival rates in a scenario of higher temperature. Our findings support that the high-risk malaria areas may include the southern region of the distribution range of the Atlantic Forest biome in the coming years. Despite its limitations and assumptions, the present study provides robust evidence of areas with potential to be impacted by malaria incidence in a future scenario. These areas should be monitored in the next decades regarding the occurrence of the mosquito vector and the potential for malaria persistence and increased occurrence.
Asunto(s)
Anopheles/parasitología , Malaria Falciparum/parasitología , Malaria Vivax/parasitología , Plasmodium falciparum/parasitología , Plasmodium vivax/parasitología , Animales , Anopheles/fisiología , Brasil/epidemiología , Cambio Climático , Ecosistema , Bosques , Humanos , Malaria/epidemiología , Malaria Falciparum/epidemiología , Malaria Vivax/epidemiología , Mosquitos Vectores/parasitología , Mosquitos Vectores/fisiologíaRESUMEN
The malaria parasite (Plasmodium sp.) contains a plastid-derived organelle called the apicoplast, which is essential for the growth of the parasite. In this organelle, a redox system comprising plant-type ferredoxin (Fd) and Fd: NADP(H) oxidoreductase (FNR) supplies reducing power for the crucial metabolic pathways. Electron transfer between Plasmodium falciparum Fd (PfFd) and FNR (PfFNR) is performed with higher affinity and specificity than those of plant Fd and FNR. We investigated the structural basis for such superior protein-protein interaction by focussing on the Plasumodium-specific regions of PfFd. Significant contribution of the C-terminal region of PfFd for the electron transfer with PfFNR was revealed by exchanging the C-terminal three residues between plant Fd and PfFd. Further site-directed mutagenesis of the PfFd C-terminal residues indicated that the presence of aromatic residue at Positions 96 and 97 contributes to the lower Km for PfFNR. Physical binding analyses using fluorescence and calorimetric measurements supported the results. A mutation from Asp to Tyr at position 97 of PfFd was recently reported to be strongly associated with P. falciparum resistance to artemisinin, the front line anti-malarial drug. Thus, the enhanced interaction of PfFd D97Y protein with PfFNR could be involved in artemisinin resistance of human malaria parasites.
Asunto(s)
Artemisininas/farmacología , Ferredoxina-NADP Reductasa/metabolismo , Ferredoxinas/metabolismo , Malaria Falciparum/parasitología , Plasmodium falciparum/efectos de los fármacos , Plasmodium falciparum/enzimología , Proteínas Protozoarias/metabolismo , Secuencia de Aminoácidos , Antimaláricos/farmacología , Cristalografía por Rayos X/métodos , Resistencia a Medicamentos , Ferredoxinas/química , Humanos , Malaria Falciparum/tratamiento farmacológico , Malaria Falciparum/metabolismo , Modelos Moleculares , Mutagénesis Sitio-Dirigida/métodos , Plasmodium falciparum/parasitología , Proteínas Protozoarias/química , Homología de SecuenciaRESUMEN
Antecedentes: Los viajes a zonas endémicas con parásitos resistentes, la respuesta evolutiva de Plasmodium y los sistemas sanitarios debilitados, comprometen el control mundial y local de la malaria. Descripción del Caso clínico: Niño, 6 años, atendido en Hospital Escuela Universitario (HE), Tegucigalpa, referido desde Siguatepeque, Comayagua, por dudas en diagnóstico de laboratorio y antecedente de vivir en África y cuatro episodios de malaria por P. falciparum (2015-2017). Al ingreso presentó cuadro entérico e informe de Plasmodium spp. Se inició tratamiento con cloroquina, omitida y substituida al día siguiente por derivado de artemisinina al confirmar P. falciparum y 0.7% de eritrocitos parasitados. Presentó buena respuesta clínica y parasitológica, egresando al 7mo día intrahospitalario después de 72 horas afebril. La gota gruesa al egreso informó estadios sexuales de P. falciparum, administrándose primaquina al estar disponible 7 días después. En control ambulatorio al 5to día post-egreso, no se observaron parásitos aunque persistían leucocitos con pigmento malárico fagocitado. Cuatro familiares convivientes en África fueron examinados. El padre, que informó cefalea leve y febrícula, fue detectado con estadios asexuales de P. falciparum; presentó buena respuesta al tratamiento con derivado de artemisinina. Conclusiones: La descripción del caso y los diferentes eslabones en su manejo clínico y epidemiológico, reflejan la potencialidad de complicación de la malaria. La introducción de parásitos resistentes a la cloroquina constituye una amenaza de salud pública, principalmente ante fallas evitables en el sistema sanitario. Es necesario fortalecer el diagnóstico temprano y tratamiento oportuno especialmente en el contexto de la eliminación de malaria en Mesoamérica...(AU)
Asunto(s)
Humanos , Masculino , Niño , Plasmodium falciparum , Plasmodium falciparum/parasitología , Malaria/diagnóstico , Salud Pública , Control Sanitario de ViajerosRESUMEN
INTRODUCTION: In the face of environmental and climatic changes both ongoing and planned, the epidemiology of malaria in the city of Kaedi (Mauritania), along the Senegal River Valley, requires special attention. Some cases of malaria have been registered in the health facilities throughout the year, with an average of 150,000 annual suspected cases and climatic and ecological conditions which are now favorable for seasonal transmission. METHODS: We conducted two cross-sectional descriptive surveys in the city of Kaedi in September 2014 (wet season) and in May 2015 (dry season). Our cluster sampling involved 700 households. Microscopic examination was performed in all household members. Furthermore, larval surveys, early morning wildlife spraying and nocturnal traps breaking were performed. RESULTS: During both seasons, 9.313 thick smears were manufactured, 15 were positive, with a plasmodium prevalence rate of 0.16%. Among these, 12 were positive in the dry season and 3 in the rainy season. Plasmodium prevalence rate was 0.26% and 0.06% respectively in the dry season (n = 4642) and in the wet season (n = 4671). In the rainy season, rates were 0.04% (2/4671) and 0.02% (1/4671) respectively for Plasmodium malariae and Plasmodium falciparum. The only species found in the dry season was Plasmodium falciparum. Entomological investigations showed the presence of a single species of Anopheles mosquito, Anopheles gambia (two in the rainy season and six in the dry season). Larval surveys showed that the larval fauna was dominated by Culex larvae (99.6%). Anopheles larvae (0.4%) were collected only during the dry season. CONCLUSION: Despite low malaria transmission in the city of Kaedi, in a context of lack of rainfall, health authorities should implement a strategy for malaria elimination in the wilayas of the Senegal River.
Asunto(s)
Malaria/epidemiología , Plasmodium malariae/aislamiento & purificación , Ríos/parasitología , Animales , Anopheles/parasitología , Cambio Climático , Estudios Transversales , Culex/parasitología , Fenómenos Ecológicos y Ambientales , Femenino , Humanos , Larva/crecimiento & desarrollo , Larva/parasitología , Malaria/sangre , Malaria/parasitología , Malaria/transmisión , Masculino , Mauritania/epidemiología , Plasmodium falciparum/aislamiento & purificación , Plasmodium falciparum/parasitología , Plasmodium malariae/parasitología , Prevalencia , Estaciones del Año , Senegal/epidemiologíaRESUMEN
Malaria transmission remains high in Sub-Saharan Africa despite large-scale implementation of malaria control interventions. A comprehensive understanding of the transmissibility of infections to mosquitoes may guide the design of more effective transmission reducing strategies. The impact of P. falciparum sexual stage immunity on the infectious reservoir for malaria has never been studied in natural settings. Repeated measurements were carried out at start-wet, peak-wet and dry season, and provided data on antibody responses against gametocyte/gamete antigens Pfs48/45 and Pfs230 as anti-gametocyte immunity. Data on high and low-density infections and their infectiousness to anopheline mosquitoes were obtained using quantitative molecular methods and mosquito feeding assays, respectively. An event-driven model for P. falciparum sexual stage immunity was developed and fit to data using an agent based malaria model infrastructure. We found that Pfs48/45 and Pfs230 antibody densities increased with increasing concurrent gametocyte densities; associated with 55-70% reduction in oocyst intensity and achieved up to 44% reduction in proportions of infected mosquitoes. We showed that P. falciparum sexual stage immunity significantly reduces transmission of microscopic (p < 0.001) but not submicroscopic (p = 0.937) gametocyte infections to mosquitoes and that incorporating sexual stage immunity into mathematical models had a considerable impact on the contribution of different age groups to the infectious reservoir of malaria. Human antibody responses to gametocyte antigens are likely to be dependent on recent and concurrent high-density gametocyte exposure and have a pronounced impact on the likelihood of onward transmission of microscopic gametocyte densities compared to low density infections. Our mathematical simulations indicate that anti-gametocyte immunity is an important factor for predicting and understanding the composition and dynamics of the human infectious reservoir for malaria.
Asunto(s)
Malaria/transmisión , Glicoproteínas de Membrana/inmunología , Plasmodium falciparum/fisiología , Proteínas Protozoarias/inmunología , Animales , Antígenos de Protozoos/inmunología , Antígenos de Protozoos/metabolismo , Enfermedades Transmisibles/transmisión , Culicidae , Humanos , Insectos Vectores , Malaria Falciparum/genética , Malaria Falciparum/inmunología , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/metabolismo , Plasmodium falciparum/inmunología , Plasmodium falciparum/parasitología , Proteínas Protozoarias/genética , Proteínas Protozoarias/metabolismoRESUMEN
In malaria-endemic areas, Plasmodium falciparum prevalence is often high in young women because of 1) low use of insecticide-treated nets before their first pregnancy and 2) acquired immunity, meaning infections are asymptomatic and thus untreated. Consequently, a common source of malaria in pregnancy (MiP) may be infected women becoming pregnant, rather than pregnant women becoming infected. In this study, prevalence of infection was determined by microscopy at first antenatal care (ANC) visit in primigravidae and secundigravidae in Ghana, Burkina Faso, Mali, and The Gambia, four countries with strong seasonal variations in transmission. Duration of pregnancy spent in the rainy season and other risk factors for infection were evaluated using multivariable Poisson regression. We found that the overall prevalence of malaria at first ANC was generally high and increased with time spent pregnant during the rainy season: prevalence among those with the longest exposure was 59.7% in Ghana, 56.7% in Burkina Faso, 42.2% in Mali, and 16.8% in Gambia. However, the prevalence was substantial even among women whose entire pregnancy before first ANC had occurred in the dry season: 41.3%, 34.4%, 11.5%, and 7.8%, respectively, in the four countries. In multivariable analysis, risk of infection was also higher among primigravidae, younger women, and those of lower socioeconomic status, independent of seasonality. High prevalence among women without exposure to high transmission during their pregnancy suggests that part of the MiP burden results from long-duration infections, including those acquired preconception. Prevention of malaria before pregnancy is needed to reduce the MiP burden.
Asunto(s)
Transmisión Vertical de Enfermedad Infecciosa/estadística & datos numéricos , Malaria/transmisión , Estaciones del Año , Adolescente , Adulto , África Occidental/epidemiología , Antimaláricos/uso terapéutico , Femenino , Humanos , Malaria/epidemiología , Plasmodium falciparum/parasitología , Plasmodium falciparum/patogenicidad , Embarazo , Atención Prenatal/métodos , Atención Prenatal/normas , Atención Prenatal/estadística & datos numéricos , Prevalencia , Pirimetamina/uso terapéutico , Sulfadoxina/uso terapéuticoRESUMEN
Artemisinin combination therapy is recommended for the treatment of multidrug resistant Plasmodium falciparum and Plasmodium vivax. In March 2006, antimalarial policy in Indonesia was changed to a unified treatment with dihydroartemisinin-piperaquine for all species of malaria because of the low efficacy of previous drug treatments. In 2013, a randomized cross-sectional household survey in Papua was used to collect data on demographics, parasite positivity, treatment-seeking behavior, diagnosis and treatment of malaria, and household costs. Results were compared with a similar survey undertaken in 2005. A total of 800 households with 4,010 individuals were included in the 2013 survey. The prevalence of malaria parasitemia was 12% (348/2,795). Of the individuals who sought treatment of fever, 67% (66/98) reported attending a public provider at least once compared with 46% (349/764) before policy change (P < 0.001). During the 100 visits to healthcare providers, 95% (95) included a blood test for malaria and 74% (64/86) resulted in the recommended antimalarial for the diagnosed species, the corresponding figures before policy change were 48% (433/894) and 23% (78/336). The proportion of individuals seeking treatment more than once fell from 14% (107/764) before policy change to 2% (2/98) after policy change (P = 0.005). The mean indirect cost per fever episode requiring treatment seeking decreased from US$44.2 in 2005 to US$33.8 in 2013 (P = 0.006). The implementation of a highly effective antimalarial treatment was associated with better adherence of healthcare providers in both the public and private sectors and a reduction in clinical malaria and household costs.
Asunto(s)
Antimaláricos/farmacología , Combinación de Medicamentos , Conducta de Búsqueda de Ayuda , Malaria/tratamiento farmacológico , Adolescente , Antimaláricos/uso terapéutico , Artemisininas/farmacología , Artemisininas/uso terapéutico , Niño , Preescolar , Estudios Transversales , Femenino , Conductas Relacionadas con la Salud , Humanos , Indonesia , Lactante , Masculino , Plasmodium falciparum/parasitología , Plasmodium falciparum/patogenicidad , Plasmodium vivax/parasitología , Plasmodium vivax/patogenicidad , Quinolinas/farmacología , Quinolinas/uso terapéutico , Encuestas y CuestionariosRESUMEN
Controlled human malaria infection (CHMI) by direct venous inoculation (DVI) with 3,200 cryopreserved Plasmodium falciparum sporozoites (PfSPZ) consistently leads to parasitemia and malaria symptoms in malaria-naive adults. We used CHMI by DVI to investigate infection rates, parasite kinetics, and malaria symptoms in lifelong malaria-exposed (semi-immune) Gabonese adults with and without sickle cell trait. Eleven semi-immune Gabonese with normal hemoglobin (IA), nine with sickle cell trait (IS), and five nonimmune European controls with normal hemoglobin (NI) received 3,200 PfSPZ by DVI and were followed 28 days for parasitemia by thick blood smear (TBS) and quantitative polymerase chain reaction (qPCR) and for malaria symptoms. End points were time to parasitemia and parasitemia plus symptoms. PfSPZ Challenge was well tolerated and safe. Five of the five (100%) NI, 7/11 (64%) IA, and 5/9 (56%) IS volunteers developed parasitemia by TBS, and 5/5 (100%) NI, 9/11 (82%) IA, and 7/9 (78%) IS by qPCR, respectively. The time to parasitemia by TBS was longer in IA (geometric mean 16.9 days) and IS (19.1 days) than in NA (12.6 days) volunteers (P = 0.016, 0.021, respectively). Five of the five, 6/9, and 1/7 volunteers with parasitemia developed symptoms (P = 0.003, NI versus IS). Naturally adaptive immunity (NAI) to malaria significantly prolonged the time to parasitemia. Sickle cell trait seemed to prolong it further. NAI plus sickle cell trait, but not NAI alone, significantly reduced symptom rate. Twenty percent (4/20) semi-immunes demonstrated sterile protective immunity. Standardized CHMI with PfSPZ Challenge is a powerful tool for dissecting the impact of innate and naturally acquired adaptive immunity on malaria.
Asunto(s)
Inmunidad Adaptativa/inmunología , Inmunidad Innata/inmunología , Malaria/terapia , Plasmodium falciparum/parasitología , Rasgo Drepanocítico/parasitología , Adulto , Femenino , Gabón , Humanos , Masculino , Parasitemia/sangre , Parasitemia/terapia , Plasmodium falciparum/inmunologíaRESUMEN
BACKGROUND: Plasmodium falciparum infections are especially severe in pregnant women because infected erythrocytes (IE) express VAR2CSA, a ligand that binds to placental trophoblasts, causing IE to accumulate in the placenta. Resulting inflammation and pathology increases a woman's risk of anemia, miscarriage, premature deliveries, and having low birthweight (LBW) babies. Antibodies (Ab) to VAR2CSA reduce placental parasitaemia and improve pregnancy outcomes. Currently, no single assay is able to predict if a woman has adequate immunity to prevent placental malaria (PM). This study measured Ab levels to 28 malarial antigens and used the data to develop statistical models for predicting if a woman has sufficient immunity to prevent PM. METHODS: Archival plasma samples from 1377 women were screened in a bead-based multiplex assay for Ab to 17 VAR2CSA-associated antigens (full length VAR2CSA (FV2), DBL 1-6 of the FCR3, 3D7 and 7G8 lines, ID1-ID2a (FCR3 and 3D7) and 11 antigens that have been reported to be associated with immunity to P. falciparum (AMA-1, CSP, EBA-175, LSA1, MSP1, MSP2, MSP3, MSP11, Pf41, Pf70 and RESA)). Ab levels along with clinical variables (age, gravidity) were used in the following seven statistical approaches: logistic regression full model, logistic regression reduced model, recursive partitioning, random forests, linear discriminant analysis, quadratic discriminant analysis, and support vector machine. RESULTS: The best and simplest model proved to be the logistic regression reduced model. AMA-1, MSP2, EBA-175, Pf41, and MSP11 were found to be the top five most important predictors for the PM status based on overall prediction performance. CONCLUSIONS: Not surprising, significant differences were observed between PM positive (PM+) and PM negative (PM-) groups for Ab levels to the majority of malaria antigens. Individually though, these malarial antigens did not achieve reasonably high performances in terms of predicting the PM status. Utilizing multiple antigens in predictive models considerably improved discrimination power compared to individual assays. Among seven different classifiers considered, the reduced logistic regression model produces the best overall predictive performance.
Asunto(s)
Anticuerpos Antiprotozoarios/sangre , Antígenos de Protozoos/inmunología , Malaria Falciparum/inmunología , Placenta/inmunología , Plasmodium falciparum/inmunología , Complicaciones Parasitarias del Embarazo/inmunología , Adolescente , Adulto , Camerún , Femenino , Humanos , Modelos Estadísticos , Plasmodium falciparum/parasitología , Embarazo , Complicaciones Parasitarias del Embarazo/parasitología , Adulto JovenRESUMEN
Background: Malaria programmes use Plasmodium falciparum histidine-rich protein-2 (PfHRP2) based rapid diagnos tic tests (RDTs) for malaria diagnosis. The deletion of this target antigen could potentially lead to misdiagnosis, delayed treatment and continuation of active transmission. Methods: Plasmodium falciparum isolates (n = 1162) collected in Southern Mozambique were assessed by RDTs, microscopy and/or 18SrRNA qPCR. pfhrp2 and pfhrp3 deletions were investigated in isolates from individuals who were negative by RDT but positive by microscopy and/or qPCR (n = 69) using gene-specifc PCRs, with kelch13 PCR as the parasite DNA control. Results: Lack of pfhrp2 PCR amplifcation was observed in one of the 69 isolates subjected to molecular analysis [1.45% (95% CI 0.37.8%)]. Conclusions: The low prevalence of pfhrp2 deletions suggests that RDTs will detect the vast majority of the P. falcipa rum infections. Nevertheless, active surveillance for changing deletion frequencies is required.
Asunto(s)
Humanos , Masculino , Femenino , Niño , Plasmodium falciparum/parasitología , Proteínas Protozoarias , Malaria Falciparum/diagnóstico , Secuencia de Aminoácidos , Malaria Falciparum/inmunología , Errores Diagnósticos/estadística & datos numéricos , Prueba de Diagnóstico Rápido/instrumentación , MozambiqueRESUMEN
The mechanics of DNA replication and cell cycling are well-characterized in model organisms, but less is known about these basic aspects of cell biology in early-diverging Apicomplexan parasites, which do not divide by canonical binary fission but undergo unconventional cycles. Schizogony in the malaria parasite, Plasmodium, generates ~16-24 new nuclei via independent, asynchronous rounds of genome replication prior to cytokinesis and little is known about the control of DNA replication that facilitates this. We have characterised replication dynamics in P. falciparum throughout schizogony, using DNA fibre labelling and combing to visualise replication forks at a single-molecule level. We show that origins are very closely spaced in Plasmodium compared to most model systems, and that replication dynamics vary across the course of schizogony, from faster synthesis rates and more widely-spaced origins through to slower synthesis rates and closer-spaced origins. This is the opposite of the pattern usually seen across S-phase in human cells, when a single genome is replicated. Replication forks also appear to stall at an unusually high rate throughout schizogony. Our work explores Plasmodium DNA replication in unprecedented detail and opens up tremendous scope for analysing cell cycle dynamics and developing interventions targetting this unique aspect of malaria biology.
Asunto(s)
Replicación del ADN/genética , Genoma/genética , Malaria Falciparum/genética , Plasmodium falciparum/genética , Animales , División Celular/genética , Núcleo Celular/genética , Citocinesis/genética , Desarrollo Embrionario/genética , Humanos , Malaria Falciparum/parasitología , Plasmodium falciparum/parasitología , Fase S/genéticaRESUMEN
The evolutionary relationship between plants and the malarial parasite Plasmodium falciparum is well established and underscored by the P. falciparum apicoplast, an essential chloroplast-like organelle. As a result of this relationship, studies have demonstrated that herbicides active against plants are also active against P. falciparum and thus could act as antimalarial drug leads. Here we show the converse is also true; many antimalarial compounds developed for human use are highly herbicidal. We found that human antimalarial drugs (e.g. sulfadiazine, sulfadoxine, pyrimethamine, cycloguanil) were lethal to the model plant Arabidopsis thaliana at similar concentrations to market herbicides glufosinate and glyphosate. Furthermore, the physicochemical properties of these herbicidal antimalarial compounds were similar to commercially used herbicides. The implications of this finding that many antimalarial compounds are herbicidal proffers two novel applications: (i) using the genetically tractable A. thaliana to reveal mode-of-action for understudied antimalarial drugs, and (ii) co-opting antimalarial compounds as a new source for much needed herbicide lead molecules.
Asunto(s)
Antimaláricos/farmacología , Arabidopsis/efectos de los fármacos , Herbicidas/farmacología , Arabidopsis/parasitología , Humanos , Malaria Falciparum/tratamiento farmacológico , Malaria Falciparum/parasitología , Plasmodium falciparum/efectos de los fármacos , Plasmodium falciparum/parasitología , Proguanil/farmacología , Pirimetamina/farmacología , Sulfadiazina/farmacología , Sulfadoxina/farmacología , Triazinas/farmacologíaRESUMEN
BACKGROUND: In the agenda towards malaria eradication, assessment of both malaria exposure and efficacy of anti-vectorial and therapeutic strategies is a key component of management and the follow-up of field interventions. The simultaneous use of several antigens (Ags) as serological markers has the potential for accurate evaluation of malaria exposure. Here we aimed to measure the longitudinal evolution of the background levels of immunity in an urban setting in confirmed clinical cases of malaria. METHODS: A retrospective serological cross-sectional study on was carried out using 234 samples taken from 2010 to 2013 in peri-urban sentinel facility of Cote d'Ivoire. Antibody responses to recombinant proteins or BSA-peptides, 8 Plasmodium falciparum (PfAMA1, PfMSP4, PfMSP1, PfEMP1-DBL1α1-PF13, PfLSA1-41, PfLSA3-NR2, PfGLURP and PfCSP), one P. malariae (PmCSP) and one Anopheles gambiae salivary (gSG6-P1) antigens were measured using magnetic bead-based multiplex immunoassay (MBA). Total anti- P. falciparum IgG responses against schizont lysate from african 07/03 strain (adapted to culture) and 3D7 strain was measured by ELISA. RESULTS: High prevalence (7-93%) and levels of antibody responses to most of the antigens were evidenced. However, analysis showed only marginal decreasing trend of Ab responses from 2010 to 2013 that did not parallel the reduction of clinical malaria prevalence following the implementation of intervention in this area. There was a significant inverse correlation between Ab responses and parasitaemia (P<10-3, rho = 0.3). The particular recruitment of asymptomatic individuals in 2011 underlined a high background level of immunity almost equivalent to symptomatic patients, possibly obscuring observable yearly variations. CONCLUSION: The use of cross-sectional clinical malaria surveys and MBA can help to identify endemic sites where control measures have unequal impact providing relevant information about population immunity and possible decrease of transmission. However, when immunity is substantially boosted despite observable clinical decline, a larger cohort including asymptomatic recruitment is needed to monitor the impact of control measures on level of immunity.